A 6.5-fold higher frequency of CD8+T cell responses was elicited in the nanoelicitor-treated mice compared to the saline-treated mice, showing that activated CD8+T and CD4+cells could penetrate tumors and kill tumor cells. Here, CD8A is linked to neoplasm.